Soldermann
Carole Pissot Soldermann, Rosenaue FR
Patent application number | Description | Published |
---|---|---|
20100029626 | Cyclic sulfones useful as mitochondrial sodium-calcium exchangers - The invention relates to novel compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula (I) and to the use of a compound of formula (I) for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases. | 02-04-2010 |
20120122857 | HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES - The invention relates to novel compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula (I) and to the use of a compound of formula (I) for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases. | 05-17-2012 |
Carole Pissot Soldermann, Rosenau FR
Patent application number | Description | Published |
---|---|---|
20080261973 | Sulphonamidoaniline Derivatives Being Janus Kinase Inhibitors - The invention relates to sulphonamidoanilines of formula I, | 10-23-2008 |
20080287427 | Bicyclic Amides as Kinase Inhibitors - The invention relates to compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising en a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases. | 11-20-2008 |
20090137804 | Compounds and Compositions as Protein Kinase Inhibitors - The invention relates to compounds of formula (I) | 05-28-2009 |
20110301157 | BICYCLIC AMIDES AS KINASE INHIBITORS - The invention relates to compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases. | 12-08-2011 |
Nicolas Soldermann, Basel CH
Patent application number | Description | Published |
---|---|---|
20090298824 | Organic compounds - Compounds of formula I | 12-03-2009 |
20110092505 | ORGANIC COMPOUNDS - The present invention provides novel organic compounds of Formula I: methods of use, and pharmaceutical compositions thereof. | 04-21-2011 |
20120065183 | Tetrahydro-Pyrido-Pyrimidine Derivatives - The invention relates to substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), | 03-15-2012 |
20140128370 | Tetrahydro-Pyrido-Pyrimidine Derivatives - The invention relates to substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), | 05-08-2014 |
Nicolas Soldermann, Rosenau FR
Patent application number | Description | Published |
---|---|---|
20080306064 | Benzimidazole Derivatives - Benzimidazole derivatives, methods of preparing the same and their pharmaceutical uses for the treatment of inflammatory diseases including COPD. | 12-11-2008 |
20100130469 | 2, 6-NAPHTHRIDINE DERIVATIVES - The present invention relates to novel organic compounds comprising a naphthyridine which may be mediators of a selective subset of kinases belonging to the AGC kinase family, such as for example PKC, PKD, PKN-1/2, CDK-9, MRCK-beat, PASK, PRKX, ROCK-I/II or mediators of other kinases, the selectivity of which would be depending on the structural variation thereof. | 05-27-2010 |
Nicolas Soldermann, Village-Neuf FR
Patent application number | Description | Published |
---|---|---|
20130165436 | Dihydro-Benzo-Oxazine and Dihydro-Pyrido-Oxazine Derivatives - The invention relates to dihydro-benzo-oxazine and dihydro-pyrido-oxazine compounds of the formula (I) and/or pharmaceutically acceptable salts and/or solvates thereof, | 06-27-2013 |